Total Payments
$16.1M
2024 Payments
$2.4M
Companies
3
Transactions
128
Payment Breakdown by Category
Royalty/License$16.1M (100.0%)
Food & Beverage$27.10 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $16.1M | 127 | 100.0% |
| Food and Beverage | $27.10 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bard Peripheral Vascular, Inc. | $15.2M | 115 | $0 (2024) |
| C. R. Bard, Inc. & Subsidiaries | $923,345 | 12 | $0 (2020) |
| DePuy Synthes Sales Inc. | $27.10 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2.4M | 4 | Bard Peripheral Vascular, Inc. ($2.4M) |
| 2023 | $2.4M | 4 | Bard Peripheral Vascular, Inc. ($2.4M) |
| 2022 | $2.1M | 24 | Bard Peripheral Vascular, Inc. ($2.1M) |
| 2021 | $2.0M | 25 | Bard Peripheral Vascular, Inc. ($2.0M) |
| 2020 | $1.4M | 18 | C. R. Bard, Inc. & Subsidiaries ($923,345) |
| 2019 | $1.9M | 4 | BARD PERIPHERAL VASCULAR, INC. ($1.9M) |
| 2018 | $1.7M | 23 | Bard Peripheral Vascular, Inc. ($1.7M) |
| 2017 | $2.3M | 26 | Bard Peripheral Vascular, Inc. ($2.3M) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $547,233.00 | General |
| Category: Vascular/Oncology | ||||||
| 08/14/2024 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $605,307.00 | General |
| Category: Vascular/Oncology | ||||||
| 05/15/2024 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $613,084.00 | General |
| Category: Vascular/Oncology | ||||||
| 02/14/2024 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $590,657.00 | General |
| Category: Vascular/Oncology | ||||||
| 11/07/2023 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $593,517.00 | General |
| Category: Vascular/Oncology | ||||||
| 08/02/2023 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $604,113.00 | General |
| Category: Vascular/Oncology | ||||||
| 05/15/2023 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $614,048.00 | General |
| Category: Vascular/Oncology | ||||||
| 02/14/2023 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $540,757.00 | General |
| Category: Vascular/Oncology | ||||||
| 11/18/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $538,721.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 08/10/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $326,468.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 08/10/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $123,875.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 08/10/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $26,156.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 08/10/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $20,528.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 08/10/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $16,175.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 08/10/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $14,880.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 08/10/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $1,103.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 08/10/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $260.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 05/26/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $336,198.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 05/26/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $118,387.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 05/26/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $28,532.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 05/26/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $19,263.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 05/26/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $15,096.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 05/26/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $14,599.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 05/26/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $2,455.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 05/26/2022 | Bard Peripheral Vascular, Inc. | UltraClip II Breast Tissue Marker (Device) | Royalty or License | Cash or cash equivalent | $361.00 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
About Dr. Richard Chesbrough, MD
Dr. Richard Chesbrough, MD is a Diagnostic Radiology healthcare provider based in Bingham Farms, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174572465.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Chesbrough, MD has received a total of $16.1M in payments from pharmaceutical and medical device companies, with $2.4M received in 2024. These payments were reported across 128 transactions from 3 companies. The most common payment nature is "Royalty or License" ($16.1M).
Ad
Practice Information
- Specialty Diagnostic Radiology
- Location Bingham Farms, MI
- Active Since 05/06/2006
- Last Updated 04/03/2014
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1174572465
Products in Payments
- UltraClip II Breast Tissue Marker (Device) $6.8M
- ULTRACLIP (Device) $4.8M
- BPV-BARD Chesbrough (Device) $2.3M
- CHESBROUGH (Device) $1.6M
- PER-Q-CATH (Device) $88,759
- RADPICC (Device) $19,671
- BREVIA (Device) $9,847
- ORTHOVISC (Device) $27.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.